2,854
Participants
Start Date
November 30, 2004
Primary Completion Date
July 31, 2015
Study Completion Date
August 31, 2015
Benznidazole
Daily po Benznidazole or placebo (weight based) during 40 - 80 days (depending on body weight)
Placebo
a dose calculated as 5mg/kg/day for 60 days, now administered as a fixed daily dose of 300mg during 40 - 80 days of treatment - period adjusted according to the patient's body weight to a total minimum dose of 12g (corresponding to 40kg) and a total maximum dose of 24g (corresponding to 80kg)
BENEFIT Investigational Site, Buenos Aires
BENEFIT Investigational Site, Isidro Casanova
BENEFIT Investigational Site, San Juan
BENEFIT Investigational Site, Belén de Escobar
BENEFIT Investigational Site, Rosario
BENEFIT Investigational Site, Paraná
BENEFIT Investigational Site, Corrientes
BENEFIT Ivestigational Site, Buenos Aires
BENEFIT Investigational Site, Añatuya
BENEFIT Investigational Site, Santiago Del Estero
BENEFIT Investigational Site, Santiago del Estero
BENEFIT Investigational Site, San Salvador de Jujuy
BENEFIT Investigational Site, Santiago Del Estero
BENEFIT Investigational Site, Catamarca
BENEFIT Investigational Site, Buenos Aires
BENEFIT Investigational Site, Buenos Aires
BENEFIT Investigational Site, Tupiza
BENEFIT Investigational Site, Bogotá
BENEFIT Investigational Site, San Gil
BENEFIT Ivestigational Site, San Salvador
BENEFIT Investigational Site, Charata
BENEFIT Investigational Site, Salta
BENEFIT Investigational Site, Salvador
BENEFIT Investigational Site, Salvador
BENEFIT Investigational Site, Salvador
BENEFIT Investigational Site, Carmo
BENEFIT Investigational Site, Brasília
BENEFIT Investigational Site, Goiânia
BENEFIT Investigational Site, Goiânia
BENEFIT Investigational Site, Goiânia
BENEFIT Investigational Site, Uberaba
BENEFIT Investigational Site, Uberlândia
BENEFIT Investigational Site, Uberlândia
BENEFIT Investigational Site, Curitiba
BENEFIT Investigational Site, Recife
BENEFIT Investigational Site, Pelotas
BENEFIT Investigational Site, Campinas
BENEFIT Investigational Site, Ribeirão Preto
BENEFIT Investigational Site, São José do Rio Preto
BENEFIT Investigational Site, São José do Rio Preto
BENEFIT Investigational Site, Votuporanga
BENEFIT Investigational Site, Rio de Janeiro
BENEFIT Investigational Site, Rio de Janeiro
BENEFIT Investigational Site, São Paulo
BENEFIT Investigational Site, São Paulo
BENEFIT Investigational Site, São Paulo
BENEFIT Investigational Site, São Paulo
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
World Health Organization
OTHER
Instituto Dante Pazzanese de Cardiologia
OTHER
University of Sao Paulo
OTHER
Population Health Research Institute
OTHER